The Valley Desk

NCT00704730 · Interventional trial

Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer

Overall registry status Completed

Phase 3

Conditions Thyroid Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov